{"title":"推进慢性阻塞性肺病的吸入疗法:综合考虑临床、经济和环境因素","authors":"B. Bostock","doi":"10.12968/jprp.2024.6.3.110","DOIUrl":null,"url":null,"abstract":"Chronic obstructive pulmonary disease (COPD) has a significant impact on patients and the wider health systems. COPD should be managed holistically, and pharmacological treatment with inhaled bronchodilators (singly, in combination or with inhaled corticosteroids) should be matched to patient need. Choice of inhaler type and specific device should be based on patient need and preference, as well as economic and environmental concerns.","PeriodicalId":16882,"journal":{"name":"Journal of Prescribing Practice","volume":"49 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Advancing inhaled therapy for chronic obstructive pulmonary disease: integrating clinical, economic and environmental considerations\",\"authors\":\"B. Bostock\",\"doi\":\"10.12968/jprp.2024.6.3.110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Chronic obstructive pulmonary disease (COPD) has a significant impact on patients and the wider health systems. COPD should be managed holistically, and pharmacological treatment with inhaled bronchodilators (singly, in combination or with inhaled corticosteroids) should be matched to patient need. Choice of inhaler type and specific device should be based on patient need and preference, as well as economic and environmental concerns.\",\"PeriodicalId\":16882,\"journal\":{\"name\":\"Journal of Prescribing Practice\",\"volume\":\"49 7\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Prescribing Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12968/jprp.2024.6.3.110\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Prescribing Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12968/jprp.2024.6.3.110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Advancing inhaled therapy for chronic obstructive pulmonary disease: integrating clinical, economic and environmental considerations
Chronic obstructive pulmonary disease (COPD) has a significant impact on patients and the wider health systems. COPD should be managed holistically, and pharmacological treatment with inhaled bronchodilators (singly, in combination or with inhaled corticosteroids) should be matched to patient need. Choice of inhaler type and specific device should be based on patient need and preference, as well as economic and environmental concerns.